| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |